Les Laboratoires Servier
16 products tracked · names used in filings: Les Laboratoires Servier
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Tidhesco ivosidenib | Application withdrawn | |
| 🇪🇺 | Thymanax agomelatine | Refused | |
| 🇪🇺 | Valdoxan agomelatine | Refused | |
| 🇪🇺 | Issarlos strontium ranelate;colecalciferol | Application withdrawn | |
| 🇪🇺 | Ditelos strontium ranelate;colecalciferol | Application withdrawn | |
| 🇪🇺 | Voranigo vorasidenib | Authorised | 2025-09-17 |
| 🇪🇺 | Tibsovo ivosidenib | Authorised | 2023-05-04 |
| 🇪🇺 | Onivyde pegylated liposomal (previously Onivyde) irinotecan hydrochloride trihydrate | Authorised | 2016-10-14 |
| 🇪🇺 | Lonsurf trifluridine;tipiracil | Authorised | 2016-04-25 |
| 🇪🇺 | Oncaspar pegaspargase | Authorised | 2016-01-14 |
| 🇪🇺 | Pixuvri pixantrone dimaleate | Expired | 2012-05-10 |
| 🇪🇺 | Valdoxan agomelatine | Authorised | 2009-02-19 |
| 🇪🇺 | Corlentor ivabradine | Authorised | 2005-10-25 |
| 🇪🇺 | Procoralan ivabradine | Authorised | 2005-10-25 |
| 🇪🇺 | Osseor strontium ranelate | Withdrawn | 2004-09-20 |
| 🇪🇺 | Protelos strontium ranelate | Withdrawn | 2004-09-20 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.